1. Home
  2. RVPH vs PRTS Comparison

RVPH vs PRTS Comparison

Compare RVPH & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • PRTS
  • Stock Information
  • Founded
  • RVPH 2006
  • PRTS 1995
  • Country
  • RVPH United States
  • PRTS United States
  • Employees
  • RVPH N/A
  • PRTS N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • PRTS Auto & Home Supply Stores
  • Sector
  • RVPH Health Care
  • PRTS Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • PRTS Nasdaq
  • Market Cap
  • RVPH 50.0M
  • PRTS 52.5M
  • IPO Year
  • RVPH N/A
  • PRTS 2007
  • Fundamental
  • Price
  • RVPH $1.78
  • PRTS $0.92
  • Analyst Decision
  • RVPH Strong Buy
  • PRTS Buy
  • Analyst Count
  • RVPH 4
  • PRTS 3
  • Target Price
  • RVPH $15.33
  • PRTS $1.60
  • AVG Volume (30 Days)
  • RVPH 5.1M
  • PRTS 344.6K
  • Earning Date
  • RVPH 11-14-2024
  • PRTS 10-29-2024
  • Dividend Yield
  • RVPH N/A
  • PRTS N/A
  • EPS Growth
  • RVPH N/A
  • PRTS N/A
  • EPS
  • RVPH N/A
  • PRTS N/A
  • Revenue
  • RVPH N/A
  • PRTS $611,705,000.00
  • Revenue This Year
  • RVPH N/A
  • PRTS N/A
  • Revenue Next Year
  • RVPH N/A
  • PRTS $1.58
  • P/E Ratio
  • RVPH N/A
  • PRTS N/A
  • Revenue Growth
  • RVPH N/A
  • PRTS N/A
  • 52 Week Low
  • RVPH $0.60
  • PRTS $0.68
  • 52 Week High
  • RVPH $5.67
  • PRTS $3.44
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 53.02
  • PRTS 44.83
  • Support Level
  • RVPH $1.23
  • PRTS $0.90
  • Resistance Level
  • RVPH $1.75
  • PRTS $0.99
  • Average True Range (ATR)
  • RVPH 0.53
  • PRTS 0.06
  • MACD
  • RVPH -0.07
  • PRTS -0.01
  • Stochastic Oscillator
  • RVPH 18.57
  • PRTS 26.17

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About PRTS CarParts.com Inc.

CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.

Share on Social Networks: